_version_ 1785021449287761920
author Al-Kali, Aref
Nanaa, Ahmad
Viswanatha, David
He, Rong
Nguyen, Phuong
Jevremovic, Dragan
Foran, James M.
Yi, Cecelia Arana
Greipp, Patricia T.
Gangat, Naseema
Patnaik, Mrinal
Tefferi, Ayalew
Litzow, Mark R.
Mangaonkar, Abhishek A.
Shah, Mithun Vinod
Badar, Talha
Alkhateeb, Hassan B.
author_facet Al-Kali, Aref
Nanaa, Ahmad
Viswanatha, David
He, Rong
Nguyen, Phuong
Jevremovic, Dragan
Foran, James M.
Yi, Cecelia Arana
Greipp, Patricia T.
Gangat, Naseema
Patnaik, Mrinal
Tefferi, Ayalew
Litzow, Mark R.
Mangaonkar, Abhishek A.
Shah, Mithun Vinod
Badar, Talha
Alkhateeb, Hassan B.
author_sort Al-Kali, Aref
collection PubMed
description
format Online
Article
Text
id pubmed-10083167
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100831672023-04-11 Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Al-Kali, Aref Nanaa, Ahmad Viswanatha, David He, Rong Nguyen, Phuong Jevremovic, Dragan Foran, James M. Yi, Cecelia Arana Greipp, Patricia T. Gangat, Naseema Patnaik, Mrinal Tefferi, Ayalew Litzow, Mark R. Mangaonkar, Abhishek A. Shah, Mithun Vinod Badar, Talha Alkhateeb, Hassan B. Blood Cancer J Correspondence Nature Publishing Group UK 2023-04-10 /pmc/articles/PMC10083167/ /pubmed/37032414 http://dx.doi.org/10.1038/s41408-023-00818-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Al-Kali, Aref
Nanaa, Ahmad
Viswanatha, David
He, Rong
Nguyen, Phuong
Jevremovic, Dragan
Foran, James M.
Yi, Cecelia Arana
Greipp, Patricia T.
Gangat, Naseema
Patnaik, Mrinal
Tefferi, Ayalew
Litzow, Mark R.
Mangaonkar, Abhishek A.
Shah, Mithun Vinod
Badar, Talha
Alkhateeb, Hassan B.
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title_full Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title_fullStr Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title_full_unstemmed Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title_short Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
title_sort observation and treatment in ddx41-mutated acute myeloid leukemia and myelodysplastic syndrome
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083167/
https://www.ncbi.nlm.nih.gov/pubmed/37032414
http://dx.doi.org/10.1038/s41408-023-00818-6
work_keys_str_mv AT alkaliaref observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT nanaaahmad observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT viswanathadavid observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT herong observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT nguyenphuong observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT jevremovicdragan observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT foranjamesm observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT yiceceliaarana observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT greipppatriciat observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT gangatnaseema observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT patnaikmrinal observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT tefferiayalew observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT litzowmarkr observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT mangaonkarabhisheka observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT shahmithunvinod observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT badartalha observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome
AT alkhateebhassanb observationandtreatmentinddx41mutatedacutemyeloidleukemiaandmyelodysplasticsyndrome